Article info

0152: Weekly Docetaxel and Irinotecan in Platinum-Refractory and Resistant Ovarian Cancer: a Phase II Study of the Austrian Ago

Authors

Citation

Petru E, Angleitner-Boubenizek L, Reinthaller A, et al
0152: Weekly Docetaxel and Irinotecan in Platinum-Refractory and Resistant Ovarian Cancer: a Phase II Study of the Austrian Ago
Online issue publication 
December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.